Industry News

Diabetes Technology Society Outlines Potential Post-clearance Surveillance Program To Address Inaccuracy Of Blood Glucose Monitors
Delcath Receives CRL from FDA for Melbleztm Kit NDA
Comment Request Notice on Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format Posted in Federal...
AVA Conference Will Highlight Patient Safety Gains with SwabCap, SwabFlush
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S. Sanofi Us
New FDA Regulations Streamlining the Governance of Combination Products are Detailed in New White Paper
CVS Caremark Research Finds New, More Accurate Method for Classifying Patient Medication Adherence Behaviors Results can help health care providers tailor interventions through better understanding of why patients don't take their medicinesStudy
Governor Scott Announces Johnson & Johnson Vision Care, INC. Expansion in Jacksonville, Savings from Manufacturing Sales Tax Elimination
Walgreens to Acquire Kerr Drug's Retail Drugstores and Specialty Pharmacy Business
Walgreens to Acquire Kerr Drug's Retail Drugstores and Specialty Pharmacy Business
AstraZeneca and Merck enter licence agreement for investigational oral WEE1 kinase inhibitor therapy for cancer
Bristol-Myers skin cancer drug misses study goal
Novartis announces an exclusive global licensing and research collaboration with Regenerex, leveraging a novel cell platform to broaden presence in the cell therapy space
Perrigo Company Announces FDA Final Approval For The Store Brand Equivalent To Children's Zyrtec® Allergy Syrup, 1 mg/mL
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S. Sanofi Us
Governor Scott Announces Johnson & Johnson Vision Care, INC. Expansion in Jacksonville, Savings from Manufacturing Sales Tax Elimination
AAMI Submits Comments on Cybersecurity Draft Guidance
Nutra Pharma Provides Update on Inventory and Fulfillment
Tactile Medical Launches New Wound Care Product to Treat Venous Leg Ulcers
FDA Approves ABRAXANE(R) for Pancreatic Cancer, Could Nuvilex's Treatment Be Next
Perrigo Company Announces FDA Final Approval For The Store Brand Equivalent To Children's Zyrtec Allergy Syrup, 1 mg/mL
County pledges $1M in incentives to pain-meds maker
Perrigo Company Announces FDA Final Approval For The Store Brand Equivalent To Children's Zyrtec® Allergy Syrup, 1 mg/mL
Novel Nasal Epinephrine Shows Comparable Absorption to EpiPen(R) in a Feasibility Study Needle-Free Epinephrine for Proposed Treatment of Allergy-Induced Anaphylaxis
Hospira's Inflectra(TM) (infliximab) the first biosimilar monoclonal antibody to be approved in Europe